Search

Search Constraints

You searched for: Author/Creator Brodtkorb, Thor-Henrik

Search Results

2. Comparative cost-effectiveness of tildrakizumab and other commonly used treatments for moderate-to-severe psoriasis. (3rd October 2021)

3. Cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe psoriasis in the United States. (17th February 2022)

5. Relationship between modeling technique and reported outcomes: case studies in models for the treatment of schizophrenia. (April 2014)

6. The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model. Issue 9 (16th September 2014)